James Nisco
Finanzdirektor/CFO bei LISATA THERAPEUTICS, INC.
Vermögen: 30 210 $ am 30.04.2024
Profil
James Nisco is currently the Treasurer, Chief Accounting Officer & SVP-Finance at Lisata Therapeutics, Inc. He previously worked as the Vice President-Finance & Treasury at Caladrius Biosciences, Inc. Mr. Nisco completed his undergraduate degree at State University of New York College at Oneonta and holds an MBA from Pace University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 11 357 ( 0,14% ) | 30 210 $ | 30.04.2024 |
Aktive Positionen von James Nisco
| Unternehmen | Position | Beginn |
|---|---|---|
| LISATA THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.08.2020 |
Ehemalige bekannte Positionen von James Nisco
| Unternehmen | Position | Ende |
|---|---|---|
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Finanzdirektor/CFO | - |
Ausbildung von James Nisco
| Pace University | Masters Business Admin |
| State University of New York College at Oneonta | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LISATA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
